Literature DB >> 8324127

Anaerobic bacterial infections of the lung and pleural space.

J G Bartlett1.   

Abstract

In 193 reviewed cases of pleuropulmonary infections involving anaerobic bacteria, the predominant clinical syndromes were aspiration pneumonia, lung abscess, and empyema. Most patients had an indolent infection with tissue necrosis (abscess or bronchopulmonary fistula) at initial presentation. Nevertheless, many had a more fulminant disease course resembling that of pneumococcal pneumonia. Transtracheal aspiration was the procedure most commonly used to obtain uncontaminated specimens for anaerobic culture; since this procedure now is seldom employed, pulmonary infections due to anaerobes rarely have an etiologic diagnosis at present. The dominant pathogens are Peptostreptococcus, Bacteroides, Prevotella, and Fusobacterium species. Although clindamycin is widely considered to be the antibiotic of choice, proper therapeutic trials would probably prove many antibiotics to be effective for the treatment of anaerobic pleuropulmonary infections.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8324127     DOI: 10.1093/clinids/16.supplement_4.s248

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  36 in total

1.  Anaerobic Infections of the Lung.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-06       Impact factor: 3.725

2.  Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America.

Authors:  J G Bartlett; S F Dowell; L A Mandell; T M File; D M Musher; M J Fine
Journal:  Clin Infect Dis       Date:  2000-09-07       Impact factor: 9.079

3.  BTS guidelines for the management of pleural infection.

Authors:  C W H Davies; F V Gleeson; R J O Davies
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

4.  Empyema caused by Anaeroglobus geminates, a case report with literature review.

Authors:  C-H Wang; L-P Kan; J-R Sun; C-M Yu; T Yin; T-W Huang; W-C Tsai; Y-S Yang
Journal:  Infection       Date:  2014-08-26       Impact factor: 3.553

Review 5.  Post-resection complications: abscesses, empyemas, bronchopleural fistulas.

Authors:  Matthew Egyud; Kei Suzuki
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

Review 6.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

Review 7.  Complementary Tolls in the periodontium: how periodontal bacteria modify complement and Toll-like receptor responses to prevail in the host.

Authors:  Jennifer L Krauss; Jan Potempa; John D Lambris; George Hajishengallis
Journal:  Periodontol 2000       Date:  2010-02       Impact factor: 7.589

8.  Efficacy and safety of sequential amoxicillin-clavulanate in the treatment of anaerobic lung infections.

Authors:  N Fernández-Sabé; J Carratalà; J Dorca; B Rosón; F Tubau; F Manresa; F Gudiol
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-05       Impact factor: 3.267

Review 9.  Pneumonia and empyema: causal, casual or unknown.

Authors:  Lindsay McCauley; Nathan Dean
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

10.  Bioluminescent Aspergillus fumigatus, a new tool for drug efficiency testing and in vivo monitoring of invasive aspergillosis.

Authors:  Matthias Brock; Grégory Jouvion; Sabrina Droin-Bergère; Olivier Dussurget; Marie-Anne Nicola; Oumaïma Ibrahim-Granet
Journal:  Appl Environ Microbiol       Date:  2008-09-26       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.